Skip to main content

Want a detailed portfolio tracker?

NuCana (NCNA) P/E (2017 - 2026)

NuCana (NCNA) P/E from Sep 28, 2017 to Jul 20, 2026. The TTM NuCana (NCNA) P/E is -0.17. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NuCana (NCNA)

YearP/EChange
2026-0.17-67.59%
2025-0.52-98.84%
2024-44.53-75.33%
2023-180.50-58.95%
2022-439.75-60.82%
2021-1.12K-49.10%
2020-2.20K-37.95%
2019-3.55K-71.59%
2018-12.51K+178.67%
2017-4.49KN/A

Comparison NuCana (NCNA) P/E with competitors

NuCana (NCNA) P/E is -0.17.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.02%
NBYStablecoin Development Corp0.00-102.57%
ENLVEnlivex Ltd0.07-144.70%
FGENFibroGen Inc0.24-243.44%
CHRSCoherus Biosciences Inc0.85-607.03%
FBIOFortress Biotech Inc0.95-667.09%
ORMPOramed Pharmaceuticals Inc1.50-998.14%
AGENAgenus Inc3.01-1898.37%
INVAInnoviva Inc3.15-1984.66%
VXRTVaxart Inc3.55-2221.12%
CRMDCorMedix Inc3.63-2268.15%
CVACCureVac N.V.4.45-2756.48%
GLPGGalapagos NV4.86-3003.39%
SRPTSarepta Therapeutics Inc4.88-3017.25%
ABEOAbeona Therapeutics Inc5.39-3319.26%
ABUSArbutus Biopharma Corp5.60-3443.62%
ZVRAZevra Therapeutics Inc5.89-3617.87%
SPROSpero Therapeutics Inc6.23-3821.76%
CGENCompugen Ltd6.31-3872.85%
RIGLRigel Pharmaceuticals6.87-4206.35%
SLXNSilexion Therapeutics Corp7.30-4459.72%
OMEROmeros Corporation9.26-5632.50%
AUPHAurinia Pharmaceuticals Inc9.58-5827.42%
PLXProtalix BioTherapeutics Inc10.89-6607.84%
ACADAcadia Pharmaceuticals Inc11.73-7108.30%
TBPHTheravance Biopharma Inc12.26-7427.17%
ADMAAdma Biologics Inc12.42-7520.39%
HRMYHarmony Biosciences Holdings Inc13.82-8358.17%
SABSSAB Biotherapeutics Inc14.14-8547.00%
NAGENiagen Bioscience Inc14.82-8954.48%
INCYIncyte Corp15.82-9554.68%
REGNRegeneron Pharmaceuticals Inc15.86-9575.05%
PBYIPuma Biotechnology Inc17.32-10446.90%
CPRXCatalyst Pharmaceuticals Inc17.44-10520.76%
EXELExelixis Inc17.54-10579.74%
TGTXTG Therapeutics Inc18.97-11433.06%
MDXGMimedx Group Inc20.55-12381.04%
XOMAXOMA Royalty Corp22.87-13769.01%
ARGXArgen X SE24.30-14619.52%
CTMXCytomX Therapeutics Inc24.82-14932.11%
XOMAOXOMA Royalty Corp25.34-15245.05%
HALOHalozyme Therapeutics Inc25.62-15411.71%
XOMAPXOMA Royalty Corp25.67-15439.44%
VRTXVertex Pharmaceuticals Inc27.99-16828.54%
RPRXRoyalty Pharma plc - Class A28.69-17242.53%
SLNOSoleno Therapeutics Inc29.02-17438.41%
ASNDAscendis Pharma A/S30.09-18077.93%
LGNDLigand Pharmaceuticals Inc - Class B37.91-22754.71%
APLSApellis Pharmaceuticals Inc39.02-23417.53%
BMRNBiomarin Pharmaceutical Inc42.21-25324.12%
KRYSKrystal Biotech Inc45.34-27195.46%
ONCBeiGene Ltd69.54-41654.62%
PHARPharming Group N.V.75.03-44932.33%
TECHBio-Techne Corp101.96-61026.31%
VCELVericel Corp109.92-65784.67%
ALNYAlnylam Pharmaceuticals Inc117.96-70591.30%
GMABGenmab140.29-83932.24%
TLXTelix Pharmaceuticals Ltd162.15-96996.15%
CORTCorcept Therapeutics Inc212.86-127295.28%